Actual Medicinal Product (AMP) -
Bydureon 2mg powder and solvent for prolonged-release suspension for injection vials (AstraZeneca UK Ltd)
Name Details
|
Current Name
Bydureon 2mg powder and solvent for prolonged-release suspension for injection vials
|
Start Date
12-10-2016
|
End Date
|
|
Previous Name
Bydureon 2mg powder and solvent for suspension for prolonged-release injection vials
|
Start Date
12-11-2015
|
End Date
11-10-2016
|
|
|
Abbreviated Name
Bydureon 2mg inj vials
|
Start Date
11-07-2011
|
|
Summary
- Licensed Route
- Subcutaneous
- Availability Restrictions
- Not available
- Licensing Authority
- Medicines - MHRA/EMA
- EMA Indicator
Codes
| BNF |
|
Previous BNF
06010203
|
Start Date
25-05-2012
|
End Date
03-04-2022
|
SNOMED Codes
|
Code
|
Start Date
|
End Date
|
| 19274811000001108 |
11-07-2011 |
|
Actual Medicinal Product Pack (AMPP) Information